​

Silexion Therapeutics Ownership | Who Owns Silexion Therapeutics?

OverviewFinancialsChart

Silexion Therapeutics Ownership Summary

Silexion Therapeutics is owned by 1.13% institutional investors, 8.05% insiders, and 90.82% retail investors. Two sigma securities is the largest institutional shareholder, holding 0% of SLXN shares.

SLXN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSilexion Therapeutics1.13%8.05%90.82%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Two sigma securities---
Montag a & associates---
Ubs group---
Citadel advisors---
Jones financial companies lllp---
Pflug koory---
Sbi securities---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Two sigma securities---
Montag a & associates---
Ubs group---
Citadel advisors---
Jones financial companies lllp---
Pflug koory---
Sbi securities---

Top Buyers

HolderShares% AssetsChange
Sbi securities---20.00
Jones financial companies lllp---26.00
Pflug koory---333.00
Ubs group---517.00
Montag a & associates---3.00K

Top Sellers

HolderShares% AssetsChange
Citadel advisors---20.93K
Two sigma securities---11.66K
Montag a & associates---3.00K
Ubs group---517.00
Pflug koory---333.00

Sold Out

HolderChange
Sbi securities-20.00
Jones financial companies lllp-26.00
Pflug koory-333.00
Ubs group-517.00
Montag a & associates-3.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026716.67%36,47999.18%1329.09%2-33.33%2-
Dec 31, 2025650.00%18,315260.18%-290.67%3---100.00%
Sep 30, 20254100.00%5,085-86.04%-255.84%350.00%1-
Jun 30, 20252-36,414---2---

Recent Insider Transactions

DateNameRoleActivityValue
Mar 26, 2026Shirvan Mitchell CSO and CDOSell$31.03K

SLXN Ownership FAQ

Who Owns Silexion Therapeutics?

Silexion Therapeutics shareholders are primarily institutional investors at 1.13%, followed by 8.05% insiders and 90.82% retail investors. The average institutional ownership in Silexion Therapeutics's industry, Biotech Stocks , is 35.43%, which Silexion Therapeutics falls below.

Who owns the most shares of Silexion Therapeutics?

Silexion Therapeutics’s largest shareholders are Two sigma securities (0 shares, 0%), Montag a & associates (0 shares, 0%), and Ubs group (0 shares, 0%). Together, they hold 0% of Silexion Therapeutics’s total shares outstanding.

Does Blackrock own Silexion Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Silexion Therapeutics.

Who is Silexion Therapeutics’s biggest shareholder by percentage of total assets invested?

Two sigma securities is Silexion Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Silexion Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools